{"ticker": {"uuid": "3d93b622-d0be-41d8-b5c3-b2b12a9186e4", "symbol": "MLAB", "name": "Mesa Laboratories Inc", "exchange": "NASDAQ", "country": "US", "sector": "Technology", "industry": "Scientific & Technical Instruments"}, "articles": [{"title": "Inventory turnover of Mesa Laboratories, Inc. \u2013 GETTEX:MLI", "summary": "This article provides financial information for Mesa Laboratories, Inc. (GETTEX:MLI), specifically focusing on its inventory turnover. The content is presented as part of TradingView's financial data offerings, indicating its relevance to investors tracking company performance.", "url": "https://www.tradingview.com/symbols/GETTEX-MLI/financials-statistics-and-ratios/invent-turnover/", "source_name": "TradingView", "published_at": "2026-07-10T03:10:16", "published_display": "10 Jul 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Long Path (MLAB) holds 8.6% of Mesa Laboratories, 477,126 shares", "summary": "Long Path-affiliated entities have reported an 8.6% stake in Mesa Laboratories (MLAB), totaling 477,126 shares of common stock. This beneficial ownership, which includes Long Path Smaller Companies Fund, Long Path Fund GP, Long Path Partners, Long Path Holdings LLC, William Thoma", "url": "https://www.stocktitan.net/sec-filings/MLAB/schedule-13g-a-mesa-laboratories-inc-co-amended-passive-investment-di-85b19f881029.html", "source_name": "Stock Titan", "published_at": "2026-07-07T20:09:27", "published_display": "07 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories And 2 Other Companies That May Be Priced Below Their Estimated Value", "summary": "This article identifies Mesa Laboratories (MLAB), Live Oak Bancshares (LOB), and Rush Street Interactive (RSI) as potentially undervalued stocks based on their estimated future cash flows compared to current prices. It highlights their growth prospects, financial health, and spec", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlab/mesa-laboratories/news/mesa-laboratories-and-2-other-companies-that-may-be-priced-b", "source_name": "Simply Wall Street", "published_at": "2026-07-07T17:14:25", "published_display": "07 Jul 2026 17:14", "sentiment": "positive", "sentiment_pct": 74, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories focuses on reliable measurement solutions for regulated industries", "summary": "Mesa Laboratories specializes in providing measurement instruments and services for highly regulated industries, focusing on compliance and long-term reliability. The company's solutions help organizations monitor and document critical processes, ensuring product quality and safe", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/mesa-laboratories-focuses-on-reliable-measurement-solutions-for-regulated/69714897", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T13:42:25", "published_display": "07 Jul 2026 13:42", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Labs sets $0.16 quarterly dividend, payable Sept. 15", "summary": "Mesa Labs (NASDAQ: MLAB) announced a regular quarterly dividend of $0.16 per share for its common stock. The dividend is scheduled to be paid on September 15, 2026, to shareholders of record as of August 31, 2026. The company specializes in designing and manufacturing life scienc", "url": "https://www.stocktitan.net/news/MLAB/mesa-labs-declares-quarterly-geaj3psj1ut7.html", "source_name": "Stock Titan", "published_at": "2026-07-06T14:10:59", "published_display": "06 Jul 2026 14:10", "sentiment": "positive", "sentiment_pct": 63, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Labs declares $0.16 quarterly dividend payable Sept. 15 By Investing.com", "summary": "Mesa Laboratories, Inc. (NASDAQ:MLAB) has declared a quarterly dividend of $0.16 per share, payable on September 15, 2026, to shareholders of record as of August 31, 2026. The company has a 24-year history of dividend payments, and its stock has surged 35% year-to-date, trading a", "url": "https://ca.investing.com/news/stock-market-news/mesa-labs-declares-016-quarterly-dividend-payable-sept-15-93CH-4721159", "source_name": "Investing.com Canada", "published_at": "2026-07-06T14:10:59", "published_display": "06 Jul 2026 14:10", "sentiment": "positive", "sentiment_pct": 60, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories Keeps Quarterly Dividend at $0.16 per Share, Payable Sept. 15 to Shareholders of Record Aug. 31", "summary": "Mesa Laboratories, Inc. announced that it will keep its regular quarterly dividend at $0.16 per share. This dividend is payable on September 15, 2026, to shareholders who are on record as of August 31, 2026. The announcement was made on July 6, 2026.", "url": "https://www.marketscreener.com/news/mesa-laboratories-keeps-quarterly-dividend-at-0-16-per-share-payable-sept-15-to-shareholders-of-r-ce7f5edbd88ef522", "source_name": "www.marketscreener.com", "published_at": "2026-07-06T14:10:59", "published_display": "06 Jul 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories Declares Regular Quarterly Dividend of $0.16 per Share", "summary": "Mesa Laboratories (MLAB) has declared a regular quarterly dividend of $0.16 per share, payable on September 15, 2026, to shareholders of record by August 31, 2026. The company, a leader in life science tools and quality control, noted that despite this positive financial step, fo", "url": "https://www.quiverquant.com/news/Mesa+Laboratories+Declares+Regular+Quarterly+Dividend+of+$0.16+per+Share", "source_name": "Quiver Quantitative", "published_at": "2026-07-06T14:00:00", "published_display": "06 Jul 2026 14:00", "sentiment": "positive", "sentiment_pct": 65, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MESA LABS DECLARES QUARTERLY DIVIDEND", "summary": "Mesa Laboratories, Inc. (NASDAQ:MLAB) announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. This dividend will be payable on September 15, 2026, to shareholders of record as of August 31, 2026. The company is a global ", "url": "https://www.globenewswire.com/news-release/2026/07/06/3322487/0/en/MESA-LABS-DECLARES-QUARTERLY-DIVIDEND.html", "source_name": "GlobeNewswire", "published_at": "2026-07-06T09:50:00", "published_display": "06 Jul 2026 09:50", "sentiment": "positive", "sentiment_pct": 71, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MLAB Stock Price and Chart \u2014 NASDAQ:MLAB", "summary": "This article provides a comprehensive overview of Mesa Laboratories, Inc. (MLAB) stock, including its current price, historical performance, key financial statistics, and upcoming earnings dates. It details the company's various operating segments within the health technology sec", "url": "https://www.tradingview.com/symbols/NASDAQ-MLAB/", "source_name": "TradingView", "published_at": "2026-07-05T17:42:25", "published_display": "05 Jul 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MLAB - Mesa Laboratories Inc Latest SEC Filings", "summary": "This article provides the latest SEC filings information for Mesa Laboratories Inc (MLAB), detailing its financial metrics, stock performance data, and other key company statistics. It includes financial figures like market cap, income, sales, P/E ratio, dividend information, and", "url": "https://finviz.com/stock?t=MLAB&ty=lf&p=m&b=1&page=4", "source_name": "Finviz", "published_at": "2026-07-05T17:10:59", "published_display": "05 Jul 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Mesa Laboratories, Inc. \u2013 NASDAQ:MLAB", "summary": "This article provides the \"Price to book forward\" value for Mesa Laboratories, Inc. (NASDAQ: MLAB). The content indicates a specific period and its corresponding value, along with change and percentage change. The article focuses solely on this financial metric for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-MLAB/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T14:13:13", "published_display": "28 Jun 2026 14:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Mesa Laboratories, Inc. \u2013 NASDAQ:MLAB", "summary": "This article focuses on the enterprise value to EBITDA (forward) for Mesa Laboratories, Inc. (NASDAQ: MLAB). It appears to be a financial data snippet from a larger platform rather than a detailed analysis, providing a specific financial metric for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-MLAB/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T06:09:22", "published_display": "28 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Mesa Laboratories, Inc. \u2013 MUN:MLI", "summary": "This article provides the \"Price to earnings forward\" value for Mesa Laboratories, Inc. (MUN:MLI). The content is primarily a header and mentions that the market is currently closed with no trades. It also details various products, communities, and services offered by TradingView", "url": "https://www.tradingview.com/symbols/MUN-MLI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T02:10:13", "published_display": "28 Jun 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Mesa Laboratories, Inc. \u2013 MUN:MLI", "summary": "This article provides the \"price to sales forward\" value for Mesa Laboratories, Inc. (MUN:MLI). The financial data is noted as being provided by ICE Data Services and FactSet, with SEC filings from Quartr. Details regarding the specific financial value are presented within the ma", "url": "https://www.tradingview.com/symbols/MUN-MLI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T20:40:38", "published_display": "27 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Mesa Laboratories, Inc. \u2013 NASDAQ:MLAB", "summary": "This article provides the \"Price to earnings forward\" metric for Mesa Laboratories, Inc. (NASDAQ: MLAB). The content primarily consists of navigation and boilerplate text from the TradingView platform, noting that the market is closed and no trades have occurred for the stock.", "url": "https://www.tradingview.com/symbols/NASDAQ-MLAB/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T18:40:38", "published_display": "27 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories, Inc. Actuals & Estimates (NASDAQ:MLAB)", "summary": "This article provides an overview of Mesa Laboratories, Inc. (MLAB) stock performance, financial actuals, and analyst estimates. It includes current stock price, historical highs and lows, market capitalization, volatility, and details on recent earnings and revenue. The report a", "url": "https://www.tradingview.com/symbols/NASDAQ-MLAB/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T16:09:06", "published_display": "26 Jun 2026 16:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MLAB Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Mesa Laboratories, Inc. (MLAB) stock, including analyst price targets, historical performance data, and financial metrics. It highlights that analysts have a one-year price target ranging from $94.00 to $130.00 and details the company's recent", "url": "https://www.tradingview.com/symbols/NASDAQ-MLAB/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T16:40:50", "published_display": "25 Jun 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Mesa Laboratories Inc For: 23 June By Investing.com", "summary": "This article reports on a Form 4 filing for Mesa Laboratories Inc., dated June 23, with a publication date of June 24, 2026. The content is primarily a placeholder or an auto-generated reporting piece from Investing.com, accompanied by various market data and news headlines. It i", "url": "https://au.investing.com/news/stock-market-news/form-4-mesa-laboratories-inc-for-23-june-93CH-4500815", "source_name": "Investing.com Australia", "published_at": "2026-06-24T12:40:50", "published_display": "24 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Labs SVP Brian Archbold sells $225k in stock after RSU conversion By Investing.com", "summary": "Brian Archbold, Senior Vice President of Operations at Mesa Laboratories Inc. (NASDAQ:MLAB), sold 2,516 shares of company stock for approximately $225,187 after converting restricted stock units and performance share units. The sale occurred on June 22, 2026, following recent acq", "url": "https://m.za.investing.com/news/stock-market-news/mesa-labs-svp-brian-archbold-sells-225k-in-stock-after-rsu-conversion-93CH-4340497?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-06-24T12:11:30", "published_display": "24 Jun 2026 12:11", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Labs SVP Brian Archbold sells $225k in stock after RSU conversion", "summary": "Brian David Archbold, SVP of Operations at Mesa Laboratories Inc. (NASDAQ:MLAB), sold approximately $225,187 worth of stock after converting restricted stock units and performance share units. The sale involved 2,516 shares at $89.502 per share on June 22, 2026. This followed his", "url": "https://m.uk.investing.com/news/stock-market-news/mesa-labs-svp-brian-archbold-sells-225k-in-stock-after-rsu-conversion-93CH-4740853?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-23T23:10:45", "published_display": "23 Jun 2026 23:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Labs CAO Crennen sells $39,559 in MLAB shares", "summary": "Mesa Laboratories' Chief Accounting Officer, Lyndsey Elizabeth Crennen, sold 442 shares of MLAB stock worth $39,559 to cover taxes on vested Restricted Stock Units and Performance Share Units. Prior to this sale, Crennen acquired 989 shares through RSU conversions and performance", "url": "https://m.uk.investing.com/news/stock-market-news/mesa-labs-cao-crennen-sells-39559-in-mlab-shares-93CH-4740887?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-23T19:40:30", "published_display": "23 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories (MLAB) CAO reports RSU vesting and 442-share tax sale", "summary": "Mesa Laboratories' CAO, Lyndsey Elizabeth Crennen, reported the vesting of restricted stock units (RSUs) and performance share units (PSUs), resulting in 726 shares of common stock and an additional 263-share grant. Subsequently, Crennen sold 442 shares of common stock at $89.502", "url": "https://www.stocktitan.net/sec-filings/MLAB/form-4-mesa-laboratories-inc-co-insider-trading-activity-41ed425fef46.html", "source_name": "Stock Titan", "published_at": "2026-06-23T17:40:30", "published_display": "23 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories (MLAB) CFO reports grants, RSU conversions and tax-cover share sale", "summary": "Mesa Laboratories CFO John Sakys recently engaged in several equity transactions, including receiving a grant of 2,282 shares and exercising restricted stock units (RSUs) that converted into 3,792 shares in total. He subsequently sold 2,827 shares at an average price of $89.502 p", "url": "https://www.stocktitan.net/sec-filings/MLAB/form-4-mesa-laboratories-inc-co-insider-trading-activity-34e9b036c745.html", "source_name": "Stock Titan", "published_at": "2026-06-23T16:40:30", "published_display": "23 Jun 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories (MLAB) SVP exercises RSUs and sells 2,516 shares", "summary": "Brian David Archbold, Senior Vice President of Operations at Mesa Laboratories (MLAB), recently engaged in significant stock transactions. He exercised restricted stock units (RSUs) for 3,324 shares and received an additional grant of 1,859 shares. Following these acquisitions, A", "url": "https://www.stocktitan.net/sec-filings/MLAB/form-4-mesa-laboratories-inc-co-insider-trading-activity-c248b0f4a53f.html", "source_name": "Stock Titan", "published_at": "2026-06-23T16:40:29", "published_display": "23 Jun 2026 16:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 MESA LABORATORIES INC /CO/ For: 22 June By Investing.com", "summary": "This article announces the filing of Form 144 for MESA LABORATORIES INC /CO/ on June 22nd. Form 144 is a notice of the intent to sell restricted securities. The brief notice was published by Investing.com.", "url": "https://ng.investing.com/news/stock-market-news/form-144-mesa-laboratories-inc-co-for-22-june-93CH-2568501", "source_name": "Investing.com Nigeria", "published_at": "2026-06-22T20:39:24", "published_display": "22 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MLAB (NASDAQ: MLAB) insider sale notice \u2014 2,516 shares disclosed", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQaU9jUlpZc3pNMXRHd1RaMEhMVEZRR011bl9XeE5LRGhFaWF4WVg1S0R2Ymo3N2QyeHZ0clNWZjJCN0Nmamh4cmVwZmNvT1VCcGp1RWMyaUF2OUpBbDVSRGxPc2Z1N2p2ZDE0bkJvYjI5N3N4ZzV4UUJGM1k2d3Y0VWtMNTNTYkoxVWtCOUFIM3h5aTVic3h2R1JFTld0ZkpfcE9r?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MLAB (NASDAQ: MLAB) files Rule 144 for 2,827 vested shares via Fidelity", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNM0c5SUtUYUNhZXd0anFfQXZEVGtSSGxsbW50QzRMU1l4X3ZPZk85NURMR0JFLXdQbUE1VDJNbEQ2WF9ZZV8zdlZmcHNBWVVlZU1iZlNKMHZ0d0JxSFFIZDY2dEgwNEwtUU1aRkR2U0Q4czlnbG1tRnB4NXRUQlVobWZrelY4cjlEQUt4Y0xvTUp4WmozbTNBcHVHSm1OVFhzUmVn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories: Priced for the Problem, Not the Platform", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/mesa-laboratories-priced-problem-not-084230363.html", "source_name": "GuruFocus.com", "published_at": "2026-06-17T08:42:30+00:00", "published_display": "17 Jun 2026 08:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories stock (US59064R1095): steady niche player after latest quarterly results", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNYm5DMl8yTE5OcE9UNzdha0JhYWZYNzZWNk93cmN0R0xNR19vVGZrMVYweTFmZE1meEdlbHZMVzdqNmhjSVJkSExMS1Q4NVJ6SFpYSE41TkhURnlJenRLelRwYndKR184cFZMWkE0SHR4SFZIczk0LV9YMHI1cjFITlRpMFMwTW50T2NKQnhjRXdsejE2endBekdfdjlLUjJ1N1ZHRWh4eHFVWGRFaTJmTTF4MHRtSVd2Z1QyemtkT25HZEJFQXNV?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-08T17:20:07+00:00", "published_display": "08 Jun 2026 17:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQa2ZFUVQ3TXZ1UzBza2FoTjRqcGltcC1oclVrUVdqR0Z1NTY4Um9lYnRXaUY5Sl9LNHU4a19BZllLYXhuUTRpWTFDU1lidUVrUlk4T1ltUW9NRktFU0pQNWU5bVhWTE5CaUNVdWNpZVN3cm1xMFQ5TkRJYVh5aVhtZFNGWWRwM0lCY1JBMTFGWjEwd2JkR3Yw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MESA LABORATORIES ($MLAB) Releases Q4 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNdWg4SjVkSzd3SGtiYjdYNE11LVc1RjM0THZKeEF0aUZJTHpseW9NRV9RTzZnVU95dmhIeEtXN3pjekViZWpyNjRiQ1V3akdyMUx6bUluQlFmaWNmVGZfYzZKY3pKcFl4b3l4UHU3bHplc2JYZlNmOTJ4Yzg1X1FxTkNYdGFrUE03eFVBZ0wyOEJRd01R?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/mesa-laboratories-inc-announce-fourth-173900582.html", "source_name": "GlobeNewswire", "published_at": "2026-05-05T17:39:00+00:00", "published_display": "05 May 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories, Inc. Scheduled to Release Q4 and Fiscal Year 2026 Financial Results on May 27, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPbnRXcGVWRTJqVFFreGZmdno3OXdDejRiT3NvMmhNTlNlUkFqLXU5UW1INldwb0FhMndQc0paRTJHZ1pEamYtajdpS0xhcnlIQnpsVk9BWXMwczRka2o4LUxNaFk3T245UFNPUTZPZGl5RDJqTnU0NVhCM21GeWc2TFZLaFZKLTRWMGpLempsbGJJMHBiMTZXWlBxVFpZaWk1U1dqU0Z1bUtQOTB2YXRxNkVHV2htU2MwTUx5bHZsdlJFejJvdnV1UXFmTWdHOWF6?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories: Hard To Set The Right Diagnosis (NASDAQ:MLAB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNM1BpV3o5WTR3aXpWR3ZSWV9JaXNuc1BYQ3Z2NjVjbF9rTGxIUjZDTDlibUx4S094ZEJBclVXcjY0WGJwaW9GVkUzYkxyMXZKdG1VN3V3Zk9FdXp4QXV4bUQxSU5uVVpMOHJQeEg4VmU4QWNlbHMtelk5aVMyM09veVhoUVl6WXZhYXVkQWFiYWI3Q2pF?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQMXJ6X29xdFRiYV9IT0FobHNRZ3VoOGJTSTE2R0pGMEI4OThCbXpBVFJNYVNNQjIzQ0JYT0hxbHdSQm51NVNmY2FqYnN0bGw2SUNvYjdtYWhUdXBBSFR5YUlvNF9OdmFPWGVPTXVIcDIwemN1ekctTkMxVmI0YmlINnpTWnVrZw?oc=5", "source_name": "Market source", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shareholders May Not Overlook Mesa Laboratories Insiders Selling US$634k In Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9JT3lMM0p4cTN6VF9SY1hVUHBleDRyWV9odnpYaE55RnFYZHlpYmw0dm9yT0pHQW1rRjBzWTBTSnViVGZObjBrUEgtQVA5ZzVvVV8w?oc=5", "source_name": "Moomoo", "published_at": "2025-07-29T07:00:00+00:00", "published_display": "29 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories (MLAB) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFAyX0JzcGkxRHU0cHNQME9wYURNNVZzZkhmYTJqSlFZLTB3eDJmNC1aQ3NoS1RIRHB0bENVQmY4aHFvSFUwQ1Jva3hPVjVGRUk2NEdMcUhIcnNMZw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-11T19:49:09+00:00", "published_display": "11 Aug 2016 19:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Inventory turnover of Mesa Laboratories, Inc. \u2013 GETTEX:MLI", "summary": "This article provides financial information for Mesa Laboratories, Inc. (GETTEX:MLI), specifically focusing on its inventory turnover. The content is presented as part of TradingView's financial data offerings, indicating its relevance to investors tracking company performance.", "url": "https://www.tradingview.com/symbols/GETTEX-MLI/financials-statistics-and-ratios/invent-turnover/", "source_name": "TradingView", "published_at": "2026-07-10T03:10:16", "published_display": "10 Jul 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Long Path (MLAB) holds 8.6% of Mesa Laboratories, 477,126 shares", "summary": "Long Path-affiliated entities have reported an 8.6% stake in Mesa Laboratories (MLAB), totaling 477,126 shares of common stock. This beneficial ownership, which includes Long Path Smaller Companies Fund, Long Path Fund GP, Long Path Partners, Long Path Holdings LLC, William Thoma", "url": "https://www.stocktitan.net/sec-filings/MLAB/schedule-13g-a-mesa-laboratories-inc-co-amended-passive-investment-di-85b19f881029.html", "source_name": "Stock Titan", "published_at": "2026-07-07T20:09:27", "published_display": "07 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories And 2 Other Companies That May Be Priced Below Their Estimated Value", "summary": "This article identifies Mesa Laboratories (MLAB), Live Oak Bancshares (LOB), and Rush Street Interactive (RSI) as potentially undervalued stocks based on their estimated future cash flows compared to current prices. It highlights their growth prospects, financial health, and spec", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mlab/mesa-laboratories/news/mesa-laboratories-and-2-other-companies-that-may-be-priced-b", "source_name": "Simply Wall Street", "published_at": "2026-07-07T17:14:25", "published_display": "07 Jul 2026 17:14", "sentiment": "positive", "sentiment_pct": 74, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories focuses on reliable measurement solutions for regulated industries", "summary": "Mesa Laboratories specializes in providing measurement instruments and services for highly regulated industries, focusing on compliance and long-term reliability. The company's solutions help organizations monitor and document critical processes, ensuring product quality and safe", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/mesa-laboratories-focuses-on-reliable-measurement-solutions-for-regulated/69714897", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T13:42:25", "published_display": "07 Jul 2026 13:42", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Labs sets $0.16 quarterly dividend, payable Sept. 15", "summary": "Mesa Labs (NASDAQ: MLAB) announced a regular quarterly dividend of $0.16 per share for its common stock. The dividend is scheduled to be paid on September 15, 2026, to shareholders of record as of August 31, 2026. The company specializes in designing and manufacturing life scienc", "url": "https://www.stocktitan.net/news/MLAB/mesa-labs-declares-quarterly-geaj3psj1ut7.html", "source_name": "Stock Titan", "published_at": "2026-07-06T14:10:59", "published_display": "06 Jul 2026 14:10", "sentiment": "positive", "sentiment_pct": 63, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Labs declares $0.16 quarterly dividend payable Sept. 15 By Investing.com", "summary": "Mesa Laboratories, Inc. (NASDAQ:MLAB) has declared a quarterly dividend of $0.16 per share, payable on September 15, 2026, to shareholders of record as of August 31, 2026. The company has a 24-year history of dividend payments, and its stock has surged 35% year-to-date, trading a", "url": "https://ca.investing.com/news/stock-market-news/mesa-labs-declares-016-quarterly-dividend-payable-sept-15-93CH-4721159", "source_name": "Investing.com Canada", "published_at": "2026-07-06T14:10:59", "published_display": "06 Jul 2026 14:10", "sentiment": "positive", "sentiment_pct": 60, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories Keeps Quarterly Dividend at $0.16 per Share, Payable Sept. 15 to Shareholders of Record Aug. 31", "summary": "Mesa Laboratories, Inc. announced that it will keep its regular quarterly dividend at $0.16 per share. This dividend is payable on September 15, 2026, to shareholders who are on record as of August 31, 2026. The announcement was made on July 6, 2026.", "url": "https://www.marketscreener.com/news/mesa-laboratories-keeps-quarterly-dividend-at-0-16-per-share-payable-sept-15-to-shareholders-of-r-ce7f5edbd88ef522", "source_name": "www.marketscreener.com", "published_at": "2026-07-06T14:10:59", "published_display": "06 Jul 2026 14:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories Declares Regular Quarterly Dividend of $0.16 per Share", "summary": "Mesa Laboratories (MLAB) has declared a regular quarterly dividend of $0.16 per share, payable on September 15, 2026, to shareholders of record by August 31, 2026. The company, a leader in life science tools and quality control, noted that despite this positive financial step, fo", "url": "https://www.quiverquant.com/news/Mesa+Laboratories+Declares+Regular+Quarterly+Dividend+of+$0.16+per+Share", "source_name": "Quiver Quantitative", "published_at": "2026-07-06T14:00:00", "published_display": "06 Jul 2026 14:00", "sentiment": "positive", "sentiment_pct": 65, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MESA LABS DECLARES QUARTERLY DIVIDEND", "summary": "Mesa Laboratories, Inc. (NASDAQ:MLAB) announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. This dividend will be payable on September 15, 2026, to shareholders of record as of August 31, 2026. The company is a global ", "url": "https://www.globenewswire.com/news-release/2026/07/06/3322487/0/en/MESA-LABS-DECLARES-QUARTERLY-DIVIDEND.html", "source_name": "GlobeNewswire", "published_at": "2026-07-06T09:50:00", "published_display": "06 Jul 2026 09:50", "sentiment": "positive", "sentiment_pct": 71, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MLAB Stock Price and Chart \u2014 NASDAQ:MLAB", "summary": "This article provides a comprehensive overview of Mesa Laboratories, Inc. (MLAB) stock, including its current price, historical performance, key financial statistics, and upcoming earnings dates. It details the company's various operating segments within the health technology sec", "url": "https://www.tradingview.com/symbols/NASDAQ-MLAB/", "source_name": "TradingView", "published_at": "2026-07-05T17:42:25", "published_display": "05 Jul 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MLAB - Mesa Laboratories Inc Latest SEC Filings", "summary": "This article provides the latest SEC filings information for Mesa Laboratories Inc (MLAB), detailing its financial metrics, stock performance data, and other key company statistics. It includes financial figures like market cap, income, sales, P/E ratio, dividend information, and", "url": "https://finviz.com/stock?t=MLAB&ty=lf&p=m&b=1&page=4", "source_name": "Finviz", "published_at": "2026-07-05T17:10:59", "published_display": "05 Jul 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Mesa Laboratories, Inc. \u2013 NASDAQ:MLAB", "summary": "This article provides the \"Price to book forward\" value for Mesa Laboratories, Inc. (NASDAQ: MLAB). The content indicates a specific period and its corresponding value, along with change and percentage change. The article focuses solely on this financial metric for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-MLAB/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T14:13:13", "published_display": "28 Jun 2026 14:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Mesa Laboratories, Inc. \u2013 NASDAQ:MLAB", "summary": "This article focuses on the enterprise value to EBITDA (forward) for Mesa Laboratories, Inc. (NASDAQ: MLAB). It appears to be a financial data snippet from a larger platform rather than a detailed analysis, providing a specific financial metric for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-MLAB/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T06:09:22", "published_display": "28 Jun 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Mesa Laboratories, Inc. \u2013 MUN:MLI", "summary": "This article provides the \"Price to earnings forward\" value for Mesa Laboratories, Inc. (MUN:MLI). The content is primarily a header and mentions that the market is currently closed with no trades. It also details various products, communities, and services offered by TradingView", "url": "https://www.tradingview.com/symbols/MUN-MLI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T02:10:13", "published_display": "28 Jun 2026 02:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Mesa Laboratories, Inc. \u2013 MUN:MLI", "summary": "This article provides the \"price to sales forward\" value for Mesa Laboratories, Inc. (MUN:MLI). The financial data is noted as being provided by ICE Data Services and FactSet, with SEC filings from Quartr. Details regarding the specific financial value are presented within the ma", "url": "https://www.tradingview.com/symbols/MUN-MLI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T20:40:38", "published_display": "27 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Mesa Laboratories, Inc. \u2013 NASDAQ:MLAB", "summary": "This article provides the \"Price to earnings forward\" metric for Mesa Laboratories, Inc. (NASDAQ: MLAB). The content primarily consists of navigation and boilerplate text from the TradingView platform, noting that the market is closed and no trades have occurred for the stock.", "url": "https://www.tradingview.com/symbols/NASDAQ-MLAB/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T18:40:38", "published_display": "27 Jun 2026 18:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories, Inc. Actuals & Estimates (NASDAQ:MLAB)", "summary": "This article provides an overview of Mesa Laboratories, Inc. (MLAB) stock performance, financial actuals, and analyst estimates. It includes current stock price, historical highs and lows, market capitalization, volatility, and details on recent earnings and revenue. The report a", "url": "https://www.tradingview.com/symbols/NASDAQ-MLAB/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T16:09:06", "published_display": "26 Jun 2026 16:09", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MLAB Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Mesa Laboratories, Inc. (MLAB) stock, including analyst price targets, historical performance data, and financial metrics. It highlights that analysts have a one-year price target ranging from $94.00 to $130.00 and details the company's recent", "url": "https://www.tradingview.com/symbols/NASDAQ-MLAB/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T16:40:50", "published_display": "25 Jun 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Mesa Laboratories Inc For: 23 June By Investing.com", "summary": "This article reports on a Form 4 filing for Mesa Laboratories Inc., dated June 23, with a publication date of June 24, 2026. The content is primarily a placeholder or an auto-generated reporting piece from Investing.com, accompanied by various market data and news headlines. It i", "url": "https://au.investing.com/news/stock-market-news/form-4-mesa-laboratories-inc-for-23-june-93CH-4500815", "source_name": "Investing.com Australia", "published_at": "2026-06-24T12:40:50", "published_display": "24 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Labs SVP Brian Archbold sells $225k in stock after RSU conversion By Investing.com", "summary": "Brian Archbold, Senior Vice President of Operations at Mesa Laboratories Inc. (NASDAQ:MLAB), sold 2,516 shares of company stock for approximately $225,187 after converting restricted stock units and performance share units. The sale occurred on June 22, 2026, following recent acq", "url": "https://m.za.investing.com/news/stock-market-news/mesa-labs-svp-brian-archbold-sells-225k-in-stock-after-rsu-conversion-93CH-4340497?ampMode=1", "source_name": "Investing.com South Africa", "published_at": "2026-06-24T12:11:30", "published_display": "24 Jun 2026 12:11", "sentiment": "negative", "sentiment_pct": 41, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Labs SVP Brian Archbold sells $225k in stock after RSU conversion", "summary": "Brian David Archbold, SVP of Operations at Mesa Laboratories Inc. (NASDAQ:MLAB), sold approximately $225,187 worth of stock after converting restricted stock units and performance share units. The sale involved 2,516 shares at $89.502 per share on June 22, 2026. This followed his", "url": "https://m.uk.investing.com/news/stock-market-news/mesa-labs-svp-brian-archbold-sells-225k-in-stock-after-rsu-conversion-93CH-4740853?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-23T23:10:45", "published_display": "23 Jun 2026 23:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Labs CAO Crennen sells $39,559 in MLAB shares", "summary": "Mesa Laboratories' Chief Accounting Officer, Lyndsey Elizabeth Crennen, sold 442 shares of MLAB stock worth $39,559 to cover taxes on vested Restricted Stock Units and Performance Share Units. Prior to this sale, Crennen acquired 989 shares through RSU conversions and performance", "url": "https://m.uk.investing.com/news/stock-market-news/mesa-labs-cao-crennen-sells-39559-in-mlab-shares-93CH-4740887?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-23T19:40:30", "published_display": "23 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories (MLAB) CAO reports RSU vesting and 442-share tax sale", "summary": "Mesa Laboratories' CAO, Lyndsey Elizabeth Crennen, reported the vesting of restricted stock units (RSUs) and performance share units (PSUs), resulting in 726 shares of common stock and an additional 263-share grant. Subsequently, Crennen sold 442 shares of common stock at $89.502", "url": "https://www.stocktitan.net/sec-filings/MLAB/form-4-mesa-laboratories-inc-co-insider-trading-activity-41ed425fef46.html", "source_name": "Stock Titan", "published_at": "2026-06-23T17:40:30", "published_display": "23 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories (MLAB) CFO reports grants, RSU conversions and tax-cover share sale", "summary": "Mesa Laboratories CFO John Sakys recently engaged in several equity transactions, including receiving a grant of 2,282 shares and exercising restricted stock units (RSUs) that converted into 3,792 shares in total. He subsequently sold 2,827 shares at an average price of $89.502 p", "url": "https://www.stocktitan.net/sec-filings/MLAB/form-4-mesa-laboratories-inc-co-insider-trading-activity-34e9b036c745.html", "source_name": "Stock Titan", "published_at": "2026-06-23T16:40:30", "published_display": "23 Jun 2026 16:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories (MLAB) SVP exercises RSUs and sells 2,516 shares", "summary": "Brian David Archbold, Senior Vice President of Operations at Mesa Laboratories (MLAB), recently engaged in significant stock transactions. He exercised restricted stock units (RSUs) for 3,324 shares and received an additional grant of 1,859 shares. Following these acquisitions, A", "url": "https://www.stocktitan.net/sec-filings/MLAB/form-4-mesa-laboratories-inc-co-insider-trading-activity-c248b0f4a53f.html", "source_name": "Stock Titan", "published_at": "2026-06-23T16:40:29", "published_display": "23 Jun 2026 16:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 MESA LABORATORIES INC /CO/ For: 22 June By Investing.com", "summary": "This article announces the filing of Form 144 for MESA LABORATORIES INC /CO/ on June 22nd. Form 144 is a notice of the intent to sell restricted securities. The brief notice was published by Investing.com.", "url": "https://ng.investing.com/news/stock-market-news/form-144-mesa-laboratories-inc-co-for-22-june-93CH-2568501", "source_name": "Investing.com Nigeria", "published_at": "2026-06-22T20:39:24", "published_display": "22 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MLAB (NASDAQ: MLAB) insider sale notice \u2014 2,516 shares disclosed", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQaU9jUlpZc3pNMXRHd1RaMEhMVEZRR011bl9XeE5LRGhFaWF4WVg1S0R2Ymo3N2QyeHZ0clNWZjJCN0Nmamh4cmVwZmNvT1VCcGp1RWMyaUF2OUpBbDVSRGxPc2Z1N2p2ZDE0bkJvYjI5N3N4ZzV4UUJGM1k2d3Y0VWtMNTNTYkoxVWtCOUFIM3h5aTVic3h2R1JFTld0ZkpfcE9r?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MLAB (NASDAQ: MLAB) files Rule 144 for 2,827 vested shares via Fidelity", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNM0c5SUtUYUNhZXd0anFfQXZEVGtSSGxsbW50QzRMU1l4X3ZPZk85NURMR0JFLXdQbUE1VDJNbEQ2WF9ZZV8zdlZmcHNBWVVlZU1iZlNKMHZ0d0JxSFFIZDY2dEgwNEwtUU1aRkR2U0Q4czlnbG1tRnB4NXRUQlVobWZrelY4cjlEQUt4Y0xvTUp4WmozbTNBcHVHSm1OVFhzUmVn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories: Priced for the Problem, Not the Platform", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/mesa-laboratories-priced-problem-not-084230363.html", "source_name": "GuruFocus.com", "published_at": "2026-06-17T08:42:30+00:00", "published_display": "17 Jun 2026 08:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories stock (US59064R1095): steady niche player after latest quarterly results", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNYm5DMl8yTE5OcE9UNzdha0JhYWZYNzZWNk93cmN0R0xNR19vVGZrMVYweTFmZE1meEdlbHZMVzdqNmhjSVJkSExMS1Q4NVJ6SFpYSE41TkhURnlJenRLelRwYndKR184cFZMWkE0SHR4SFZIczk0LV9YMHI1cjFITlRpMFMwTW50T2NKQnhjRXdsejE2endBekdfdjlLUjJ1N1ZHRWh4eHFVWGRFaTJmTTF4MHRtSVd2Z1QyemtkT25HZEJFQXNV?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-08T17:20:07+00:00", "published_display": "08 Jun 2026 17:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQa2ZFUVQ3TXZ1UzBza2FoTjRqcGltcC1oclVrUVdqR0Z1NTY4Um9lYnRXaUY5Sl9LNHU4a19BZllLYXhuUTRpWTFDU1lidUVrUlk4T1ltUW9NRktFU0pQNWU5bVhWTE5CaUNVdWNpZVN3cm1xMFQ5TkRJYVh5aVhtZFNGWWRwM0lCY1JBMTFGWjEwd2JkR3Yw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MESA LABORATORIES ($MLAB) Releases Q4 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNdWg4SjVkSzd3SGtiYjdYNE11LVc1RjM0THZKeEF0aUZJTHpseW9NRV9RTzZnVU95dmhIeEtXN3pjekViZWpyNjRiQ1V3akdyMUx6bUluQlFmaWNmVGZfYzZKY3pKcFl4b3l4UHU3bHplc2JYZlNmOTJ4Yzg1X1FxTkNYdGFrUE03eFVBZ0wyOEJRd01R?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/mesa-laboratories-inc-announce-fourth-173900582.html", "source_name": "GlobeNewswire", "published_at": "2026-05-05T17:39:00+00:00", "published_display": "05 May 2026 17:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories, Inc. Scheduled to Release Q4 and Fiscal Year 2026 Financial Results on May 27, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxPbnRXcGVWRTJqVFFreGZmdno3OXdDejRiT3NvMmhNTlNlUkFqLXU5UW1INldwb0FhMndQc0paRTJHZ1pEamYtajdpS0xhcnlIQnpsVk9BWXMwczRka2o4LUxNaFk3T245UFNPUTZPZGl5RDJqTnU0NVhCM21GeWc2TFZLaFZKLTRWMGpLempsbGJJMHBiMTZXWlBxVFpZaWk1U1dqU0Z1bUtQOTB2YXRxNkVHV2htU2MwTUx5bHZsdlJFejJvdnV1UXFmTWdHOWF6?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories: Hard To Set The Right Diagnosis (NASDAQ:MLAB)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNM1BpV3o5WTR3aXpWR3ZSWV9JaXNuc1BYQ3Z2NjVjbF9rTGxIUjZDTDlibUx4S094ZEJBclVXcjY0WGJwaW9GVkUzYkxyMXZKdG1VN3V3Zk9FdXp4QXV4bUQxSU5uVVpMOHJQeEg4VmU4QWNlbHMtelk5aVMyM09veVhoUVl6WXZhYXVkQWFiYWI3Q2pF?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxQMXJ6X29xdFRiYV9IT0FobHNRZ3VoOGJTSTE2R0pGMEI4OThCbXpBVFJNYVNNQjIzQ0JYT0hxbHdSQm51NVNmY2FqYnN0bGw2SUNvYjdtYWhUdXBBSFR5YUlvNF9OdmFPWGVPTXVIcDIwemN1ekctTkMxVmI0YmlINnpTWnVrZw?oc=5", "source_name": "Market source", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shareholders May Not Overlook Mesa Laboratories Insiders Selling US$634k In Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE9JT3lMM0p4cTN6VF9SY1hVUHBleDRyWV9odnpYaE55RnFYZHlpYmw0dm9yT0pHQW1rRjBzWTBTSnViVGZObjBrUEgtQVA5ZzVvVV8w?oc=5", "source_name": "Moomoo", "published_at": "2025-07-29T07:00:00+00:00", "published_display": "29 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Mesa Laboratories (MLAB) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFAyX0JzcGkxRHU0cHNQME9wYURNNVZzZkhmYTJqSlFZLTB3eDJmNC1aQ3NoS1RIRHB0bENVQmY4aHFvSFUwQ1Jva3hPVjVGRUk2NEdMcUhIcnNMZw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-11T19:49:09+00:00", "published_display": "11 Aug 2016 19:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 80, "total_relevant": 38, "sentiment_summary": {"positive": 7, "negative": 3, "neutral": 28, "score": 53, "total": 38, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 11.35, "count": 20}, {"event": "earnings", "label": "Earnings", "weight": 4.4, "count": 8}, {"event": "capital_return", "label": "Capital return", "weight": 3.3, "count": 6}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 95.61, "latest_week": "2026-07-10", "one_week_move": -9.4, "four_week_move": -9.4, "twelve_week_move": -7.1, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.519329, "market_dynamics_buy_signal": false, "relative_strength": -1.311347, "fair_value_gap": -7.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "positive", "expectation_probability": 55.3398, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-9.4% over one week, -9.4% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 61, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 9}, {"label": "Stock Titan", "count": 7}, {"label": "Quiver Quantitative", "count": 3}, {"label": "GlobeNewswire", "count": 2}, {"label": "Investing.com", "count": 2}, {"label": "Simply Wall Street", "count": 1}, {"label": "AD HOC NEWS", "count": 1}, {"label": "Investing.com Canada", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 38}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 20}, {"label": "Earnings", "count": 8}, {"label": "Capital return", "count": 6}, {"label": "Deals and strategy", "count": 2}, {"label": "Balance sheet", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "38", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-9.4% over one week, -9.4% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Inventory turnover of Mesa Laboratories, Inc. \u2013 GETTEX:MLI"}], "updated_at": "2026-07-16T13:31:58.136746+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}